EOM Pharmaceuticals Holdings, Inc.
IMUC
$0.1388
-$0.0099-6.66%
OTC PK
| 03/31/2022 | 12/31/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 461.09% | -61.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 90.29% | -17.63% | |||
| Operating Income | -90.29% | 17.63% | |||
| Income Before Tax | 73.34% | -473.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 73.34% | -473.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 73.34% | -473.91% | |||
| EBIT | -90.29% | 17.63% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 90.60% | -612.62% | |||
| Normalized Basic EPS | 33.85% | -1.56% | |||
| EPS Diluted | 86.74% | -632.04% | |||
| Normalized Diluted EPS | 33.85% | -1.56% | |||
| Average Basic Shares Outstanding | 182.16% | -19.71% | |||
| Average Diluted Shares Outstanding | 182.16% | -19.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||